CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK COVERED BONDS
| Bid procedure, 2021-09-30 | |
| Bonds | SWEDBANK HYPOTEK AB: 196. SE0015244991. 2026-03-18 STADSHYPOTEK AB: 1587, SE0010441303, 2023-06-01 SWEDISH COVERED BOND: 147, SE0009383664, 2026-06-17 SKANDINAVISKA ENSKILDA: 575, SE0010546572, 2022-12-21 LANSFORSAKRINGAR HYPOTEK: 516, SE0009190390, 2023-09-20 DANSKE HYPOTEK AB: 2512, SE0013877214, 2025-12-17 NORDEA HYPOTEK AB: 5534, SE0012230415, 2024-09-18 |
| Bid date | 2021-09-30 |
| Bid times | 09.00-10.00 (CET/CEST) on the Bid date |
| Requested volume (corresponding nominal amount) | 196: 400 mln SEK +/-200 mln SEK 1587: 1900 mln SEK +/-950 mln SEK 147: 700 mln SEK +/-350 mln SEK 575: 500 mln SEK +/-250 mln SEK 516: 600 mln SEK +/-300 mln SEK 2512: 500 mln SEK +/-250 mln SEK 5534: 400 mln SEK +/-200 mln SEK |
| Highest permitted bid volume (corresponding nominal amount) | 196: 400 mln SEK per bid 1587: 1900 mln SEK per bid 147: 700 mln SEK per bid 575: 500 mln SEK per bid 516: 600 mln SEK per bid 2512: 500 mln SEK per bid 5534: 400 mln SEK per bid |
| Lowest permitted bid volume (corresponding nominal amount) | SEK 50 million per bid |
| Expected allocation time | Not later than 10.15 (CET/CEST) on the Bid date |
| Delivery and payment date | 2021-10-04 |
| Delivery of bonds | To the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 |
Stockholm, 2021-09-24
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Forløb af ordinær generalforsamling den 23. april 2024 i Investeringsforeningen Danske Invest23.4.2024 17:52:33 CEST | pressemeddelelse
Beretningen og årsrapporten for 2023 for Investeringsforeningen Danske Invest blev godkendt på dagens ordinære generalforsamling. Samtidig blev de foreslåede udbytter for 2023 vedtaget. De samlede udbytter for foreningen blev 2,3 mia. kroner. Til foreningens bestyrelse blev advokat Bo Holse, direktør Birgitte Brinch Madsen, direktør Jeanette Fangel Løgstrup, direktør Jan Madsen og professor Michael Svarer genvalgt. Bestyrelsen konstituerede sig efterfølgende med Bo Holse som formand og Birgitte Brinch Madsen som næstformand. Herudover blev Price Waterhouse Coopers Statsautoriseret Revisionspartnerselskab genvalgt som revisor for foreningen. Generalforsamlingen godkendte ikke investorforslag om ændringer til afdeling Global Sustainable Future 2 KL. Bestyrelsen havde fremsat nedenstående forslag om fusioner: Fusion af afdeling Horisont 20 – Akkumulerende KL og den finske afdeling Nordea Plan Konservativ Fund med sidstnævnte afdeling som fortsættende. Fusion af afdeling Horisont 35 – Akku
Corline Biomedical publicerar årsredovisning för 202323.4.2024 17:48:21 CEST | Pressemelding
Corline Biomedical AB (”Corline”) publicerar idag sin årsredovisning för bokföringsåret 2023, vilken tillgängliggörs via bolagets hemsida www.corline.se. För mer information om Corline, vänligen kontakta Henrik Nittmar, VD Telefon: +46 (0)18 71 30 90 E-post: henrik.nittmar@corline.se Redeye AB är Corlines Certified Adviser. Corline Biomedical AB, noterat på First North Growth Market (CLBIO), arbetar med den kroppsegna substansen heparin och har utvecklat en portfölj med läkemedelskandidater för användning i anslutning till organ- och celltransplantation. Bolaget är i färd med att inleda fas 2-studier för Renaparin®, en kandidat för vilken Corline har erhållit särläkemedelsdesignering (”Orphan Drug”) i Europa och USA och som är under utveckling för att förbättra utfallet av njurtransplantation. Sedan tidigare ytbelägger bolaget medicintekniska produkter och har bland annat behandlat över 100 000 hjärtstentar som implanterats i patienter. Bolaget har tecknat avtal om samarbete med ett an
Ageas and BNP Paribas: Transparency notification23.4.2024 17:45:00 CEST | Press release
Ageas and BNP Paribas: Transparency notification In accordance with the rules on financial transparency*, BNP Paribas has notified Ageas on 22 April 2024 that, on 19 April 2024, its interest has exceeded the legal threshold of 5% of the shares issued by Ageas. Its current shareholding stands at 6.65%. Reason for the notification Acquisition or disposal of voting securities or voting rights Notification by A parent undertaking or a controlling person Persons subject to the notification requirement See annex 1a Date on which the threshold is crossed 19 April 2024 Threshold that is crossed (in %) 5% Denominator 187,971,187 Notified details See annex 1 b Chain of controlled undertakings through which the holding is effectively held, if applicable The full chain of command can be found on https://www.ageas.com/investors/shareholders Additional information BNP Paribas Cardif S.A. and BNP Paribas Fortis SA/NV are both controlled by BNP Paribas S.A.. BNP Paribas S.A. is not a controlled entity
Ageas and Fosun: Transparency notification23.4.2024 17:40:00 CEST | Press release
Ageas and Fosun: Transparency notification In accordance with the rules on financial transparency*, Fosun has notified Ageas on 22 April 2024 that, on 19 April 2024, its interest has fallen below the legal threshold of 5% of the shares issued by Ageas. Its current shareholding stands at 4.64%. Reason for the notification Acquisition or disposal of voting securities or voting rights Notification by A parent undertaking or a controlling person Persons subject to the notification requirement See annex 1a. Date on which the threshold is crossed 19 April 2024 Threshold that is crossed (in %) 5% Denominator 187,971,187 Notified details See annex 1b. Chain of controlled undertakings through which the holding is effectively held, if applicable The full chain of command can be found on https://www.ageas.com/investors/shareholders Additional information Mr. Guo Guangchang controls Fosun International Holdings Ltd., which controls Fosun Holdings Limited, which controls Fosun International Limited
Síminn hf. - Results for the first quarter of 202423.4.2024 17:34:42 CEST | Press release
Financial highlights Q1 2024 Revenue in the first quarter (Q1) of 2024 amounted to ISK 6,575 million compared to ISK 6,298 million in the same period 2023 and increased by 4.4%. Revenue from Síminn's core services, mobile, data and TV services increases by just over 7% from Q1 2023.EBITDA amounted to ISK 1,435 million in Q1 2024, up by ISK 120 million or 9.1% compared to the same period 2023. The EBITDA ratio was 21.8% in Q1 2024, compared to 20.9% in the same period of 2023. Operating profit EBIT amounted to ISK 431 million in Q1 2024 compared to ISK 318 million in the same period of 2023.Net financial expenses amounted to ISK 195 million in Q1 2024, compared to ISK 1 million in the same period of 2023. Interest expenses have increased, but there was also interest income from a bond due to the sale of Míla in Q1 2023. Financial expenses amounted to ISK 375 million, financial income ISK 183 million and foreign exchange loss of ISK 3 million.Profit in Q1 2024 amounted to ISK 171 million